Error loading player: No playable sources found
New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma
Learning Objectives
- Recognize the importance of developing additional treatment strategies for patients with advanced/metastatic esophageal squamous cell carcinoma.
- Describe the role of immune checkpoint inhibitors in the treatment of patients with advanced/metastatic esophageal squamous cell carcinoma.
- Review the available evidence on the use of nivolumab in treatment of advanced/metastatic esophageal squamous cell carcinoma.
Speaker
Michael K. Gibson, MD, PhD
Vanderbilt-Ingram Cancer Center
